When Christine Wood received a $12,000 bill from Bristol Hospital, she thought it must be a mistake. It was more than she and her husband made in a month combined. “I’m freaking out,” said Wood, who lives in a 1,700-square-foot home in Terryville, a village just outside Bristol, Connecticut. “I don’t understand it.” Wood, 52,…
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she said. The 31-year-old compliance consultant from Hendersonville, Tennessee, said she couldn’t stop vomiting. “Sunday morning, it all hits,” McClain recalled, as she described what happened…
The Trump administration’s deep cuts to federal health agencies have become a political liability after a deadly outbreak of hantavirus aboard a cruise ship and the spread of an even more fearsome disease, Ebola, in Africa. At least that’s the way many Democrats see it. They have seized on the situation to charge that the…
By MATTHEW HOLT More tales of the woes of dealing with health insurance. I live in Marin County, California and one of the things that comes with that is a diagnosis of ADHD for my children. (OK, I have made that joke before but it is true!). My kids now visit a psychiatrist for more…
While there are growing efforts to link dental health with overall health, the urgency should be felt strongly not only by pregnant women but, more importantly, by their care providers and health insurance companies. For instance, pregnant women with gum disease are 3-4 times more likely to develop pre-eclampsia, an emergency condition. The post Why…
Regeneron Pharmaceuticals’ multiple myeloma drug linvoseltamab has clinical trial results showing complete responses in 90% of patients who have light chain amyloidosis, a rare blood disease. The preliminary data were presented during the annual meeting of the American Society of Clinical Oncology. The post Regeneron Cancer Drug Shows New Promise in a Rare Disease… and…
Signos raised $20 million to expand its glucose monitoring platform for weight loss, which pairs Dexcom’s over-the-counter CGM with an app that translates glucose data into personalized diet and lifestyle recommendations. The post Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss appeared first on MedCity News.
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News.
Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address. The post Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough appeared first on MedCity News.
The real question is whether we’re being honest with ourselves about what medical education was designed to produce, and whether our current system is still doing that job. The post Medical Education Is at a Crossroads. AI Isn’t the Problem — It’s the Mirror appeared first on MedCity News.